ALKERMES | ALKS - Trade Debtors

Stock Price
37.48
Daily Change
-0.88 -2.29%
Monthly
11.00%
Yearly
19.29%
Q2 Forecast
36.35

ALKERMES reported $407.63M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
ALKERMES USD 407.63M 73.6M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 74M 8M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Malin Corporation EUR 500K 300K Dec/2024
Merck USD 11.78B 345M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Otsuka Holdings JPY 537.37B 32.95B Mar/2026
Ovoca Bio EUR 39K 408K Jun/2025
Pfizer USD 16.17B 332M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026